Evidence map›Paper›PMID 10377395›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target.

P J Jakobsson, S Thorén, R Morgenstern, B Samuelsson

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06594107 (Faktorer För Uppkomst Och Förlopp Av Axial Spondylartrit), which is not on this map. Cited by 251 papers.

0numbers the graph read from it
0cells of the map it votes in
251citing papers in PubMed
28.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06594107 recruitingnot on this mapstarted 2022, after this paper: background citation

Faktorer För Uppkomst Och Förlopp Av Axial Spondylartrit

Typeobservational_patient_registrySponsorKarolinska InstitutetRan2022 to 2035Enrolled1,000ConditionsAxial Spondyloarthritis
3 · Its place in the literature

Who cites it

251 citing papers in PubMed, 993 citations in OpenAlex.

  1. Trial
  2. Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.Cancer prevention research (Philadelphia, Pa.) · 2013
    Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Microsomal Prostaglandin E Synthase-1 Controls Colonic Prostaglandin EInternational journal of molecular sciences · 2024
    Article
  13. Prostaglandin ETemperature (Austin, Tex.) · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Update on the pathological roles of prostaglandin ETranslational neurodegeneration · 2023
    Review
  18. Review
  19. The Link between Prostanoids and Cardiovascular Diseases.International journal of molecular sciences · 2023
    Review
  20. Review

191 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

P J JakobssonDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden. per-johan.jakobsson@mbb.ki.se
S Thorén
R Morgenstern
B Samuelsson
Karolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human prostaglandin (PG) E synthase (EC 5.3.99.3) is a member of a recently recognized protein superfamily consisting of membrane associated proteins involved in eicosanoid and glutathione metabolism (the MAPEG family). Previous designations of the protein are PIG12 and MGST1-L1. PGE synthase was expressed in Escherichia coli, and both cytosolic and membrane fractions were prepared. Western blot analysis specifically detected a 15- to 16-kDa protein in the membrane fraction. Both fractions were incubated with prostaglandin H2 in the presence or absence of reduced glutathione. The membrane but not the cytosolic fraction was found to possess high glutathione-dependent PGE synthase activity (0.25 micromol/min/mg). The human tissue distribution was analyzed by Northern blot analysis. High expression of PGE synthase mRNA was detected in A549 and HeLa cancer cell lines. Intermediate level of expression was demonstrated in placenta, prostate, testis, mammary gland, and bladder whereas low mRNA expression was observed in several other tissues. A549 cells have been used as a model system to study cyclooxygenase-2 induction by IL-1beta. If A549 cells were grown in the presence of IL-1beta, a significant induction of the PGE synthase was observed by Western blot analysis. Also, Western blot analysis specifically detected a 16-kDa protein in sheep seminal vesicles. In summary, we have identified a human membrane bound PGE synthase. The enzyme activity is glutathione-dependent, and the protein expression is induced by the proinflammatory cytokine IL-1beta. PGE synthase is a potential novel target for drug development.

Indexed as

Amino Acid SequenceBase SequenceCell MembraneDrug Delivery SystemsDrug DesignEnzyme InductionGlutathioneHeLa CellsHumansInterleukin-1Intramolecular OxidoreductasesMolecular Sequence DataOrgan SpecificityProstaglandin-E SynthasesRNA, MessengerGlutathioneInterleukin-1Intramolecular OxidoreductasesProstaglandin-E SynthasesRNA, Messenger

Identifiers

PMID10377395
PMCPMC22058
OpenAlexW2062818585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.